# Frost & Sullivan Report: AI-enabled Preclinical Development, VeriSIM Life

Frost & Sullivan’s Competitive Strategy Leadership Award recognizes the company with a stand-out approach to achieving top-line growth and a superior customer experience.

This report documents Frost & Sullivan analyst research on VeriSIM Life and the company's BIOiSIM deep technology platform. The analysis evaluates the company's performance across 10 key dimensions:

- _Strategy Effectiveness_
- _Strategy Execution_
- _Competitive Differentiation_
- _Executive Team Alignment_
- _Stakeholder Integration_
- _Price/Performance Value_
- _Customer Purchase Experience_
- _Customer Ownership Experience_
- _Customer Service Experience_
- _Brand Equity_

[Download the report](https://5058440.fs1.hubspotusercontent-na1.net/hubfs/5058440/VeriSIM%20Life%20Best%20Practices%20Award%202022%20-%20Frost&Sullivan%20(2).pdf) to read Frost & Sullivan's independent assessment of VeriSIM Life and the preclinical technology services market.